Vindesine. A short review of preclinical and first clinical data
- PMID: 455579
- DOI: 10.1007/BF00257185
Vindesine. A short review of preclinical and first clinical data
Similar articles
-
[Vindesine: a new antineoplastic drug].G Clin Med. 1981 Feb;62(2):129-34. G Clin Med. 1981. PMID: 7016650 Review. Italian. No abstract available.
-
Phase I anti-cancer agents: vindesine (desacetyl vinblastine amide sulfate).Cancer Treat Rev. 1977 Jun;4(2):135-42. doi: 10.1016/s0305-7372(77)80010-8. Cancer Treat Rev. 1977. PMID: 329987 Review. No abstract available.
-
The comparative clinical pharmacology and pharmacokinetics of vindesine, vincristine, and vinblastine in human patients with cancer.Med Pediatr Oncol. 1982;10(2):115-27. doi: 10.1002/mpo.2950100202. Med Pediatr Oncol. 1982. PMID: 7070351
-
A comparative randomized trial of vinca alkaloids in patients with metastatic breast carcinoma.Cancer. 1985 Jan 15;55(2):337-40. doi: 10.1002/1097-0142(19850115)55:2<337::aid-cncr2820550205>3.0.co;2-u. Cancer. 1985. PMID: 3880657 Clinical Trial.
-
[Vinca alkaloids, a newer group of anti-neoplastic drugs].Ugeskr Laeger. 1972 Jun 19;134(25):1315-21. Ugeskr Laeger. 1972. PMID: 4340246 Review. Danish. No abstract available.
Cited by
-
Experimental in vivo cross-resistance of vinca alkaloid drugs.Cancer Chemother Pharmacol. 1981;5(3):197-9. doi: 10.1007/BF00258480. Cancer Chemother Pharmacol. 1981. PMID: 7296754
-
A Review on Mechanistic Insight of Plant Derived Anticancer Bioactive Phytocompounds and Their Structure Activity Relationship.Molecules. 2022 May 9;27(9):3036. doi: 10.3390/molecules27093036. Molecules. 2022. PMID: 35566385 Free PMC article. Review.
-
Vindesine effect in myeloid leukemia.Cancer Chemother Pharmacol. 1982;8(3):255-9. doi: 10.1007/BF00254046. Cancer Chemother Pharmacol. 1982. PMID: 6957273
-
Vinca alkaloids as a potential cancer therapeutics: recent update and future challenges.3 Biotech. 2023 Jun;13(6):211. doi: 10.1007/s13205-023-03636-6. Epub 2023 May 24. 3 Biotech. 2023. PMID: 37251731 Free PMC article. Review.
-
Vindesine: phase II evaluation in colon cancer and description of its platelet stimulating activity.Cancer Chemother Pharmacol. 1982;9(1):41-4. doi: 10.1007/BF00296760. Cancer Chemother Pharmacol. 1982. PMID: 7139851